3928 POINT EDEN WAY, HAYWARD, CA
Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update
Annual Meeting Results: Class II Directors Elected at Arcus Biosciences
Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update
Annual Report to Security Holders
Other Events
COO Resignation - Jennifer Jarrett Steps Down from Arcus Biosciences
Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
Material disclosure
Q2
Q1
FY 2025
Q3
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13D - Ownership Report
Amended Notice of Proposed Sale of Securities
Submission Upload
Correspondence